NCT06362031View on ClinicalTrials.gov

A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart Review

WithdrawnOBSERVATIONAL

0

Timeline

Start Date

June 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions

Acute Myeloid Leukemia

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY